Pyrolysis Product Testing of Medical Pressure-Sensitive Adhesives: Methods, Standards, and Applicati

Pyrolysis product testing of medical pressure-sensitive adhesives (PSAs) identifies and quantifies the volatile and semi-volatile compounds released when acrylic, silicone, or rubber-based adhesives used in tapes, wound dressings, and transdermal patches are exposed to thermal stress. Using techniques such as pyrolysis-GC/MS, evolved gas analysis, and thermogravimetric analysis coupled with spectroscopy, accredited third-party laboratories help manufacturers satisfy the chemical characterization and degradation assessment requirements of the ISO 10993 series. This article explains the technical scope, sample types, analytical procedures, and regulatory applications of medical PSA pyrolysate detection.

Technical Overview

Medical pressure-sensitive adhesives are polymeric materials designed to bond reversibly to skin and device surfaces at room temperature with minimal applied pressure. They are formulated from acrylic esters, silicone elastomers, synthetic or natural rubber block copolymers, polyurethanes, or hydrocolloid blends, and are typically combined with tackifying resins, plasticizers, antioxidants, and crosslinking agents. Because these formulations contain residual monomers, oligomers, and organic additives, they can generate a complex mixture of degradation products when exposed to heat.

Pyrolysis refers to the thermal decomposition of a polymer in an inert atmosphere, generally at temperatures between 400 °C and 800 °C, which fragments the macromolecular chains into monomers, dimers, oligomers, cyclic species, and additive breakdown products. In practice, medically relevant thermal stress arises from high-temperature sterilization cycles, hot-melt coating and drying operations, laser cutting of drug-in-adhesive patches, prolonged storage in hot climates, transport conditions, and incineration of medical waste.

Regulatory frameworks increasingly require documented evidence that degradation products of polymeric patient-contact materials are identified and toxicologically evaluated. Key drivers include ISO 10993-1 (biological evaluation within a risk management process), ISO 10993-13 (identification and quantification of degradation products from polymeric medical devices), ISO 10993-18 (chemical characterization of materials), ISO 10993-17 (establishment of allowable limits for leachable substances), and the corresponding GB/T 16886 series adopted in China. Pyrolysis product detection provides the compositional data needed to support these assessments.

Testing Samples

Acrylic Pressure-Sensitive Adhesives

Acrylate-based systems, including 2-ethylhexyl acrylate, butyl acrylate, and methyl methacrylate copolymers, are the most widely used skin-contact adhesives. Pyrolysis testing targets residual monomers, acrylic acid, ester fragments, and oligomeric species relevant to sensitization risk.

Silicone Gel Adhesives

Crosslinked polydimethylsiloxane networks used in advanced wound care and scar management sheets are analyzed for cyclic siloxanes (D3 to D10), linear siloxane fragments, and platinum catalyst residues released during thermal decomposition.

Rubber-Based Hot-Melt Adhesives

Styrene-isoprene-styrene (SIS) and styrene-butadiene-styrene (SBS) block copolymers with hydrocarbon or rosin-ester tackifiers are screened for isoprene, styrene, limonene, dipentene, and abietic acid derivative decomposition products.

Hydrocolloid and Polyurethane Adhesives

Hydrocolloid masses containing carboxymethyl cellulose, pectin, and gelatin, as well as polyurethane-based foils, are tested for carbohydrate dehydration products, amines, isocyanate fragments, and diol degradation species.

Finished Medical Devices

Complete products such as transdermal drug delivery patches, island wound dressings, surgical and fixation tapes, ECG electrode bases, ostomy baseplates, and catheter securement devices can be tested directly, providing a realistic profile of releasable compounds.

Raw Materials and Coated Films

Monomers, tackifier resins, cured adhesive films, and coated release liners are analyzed for incoming material verification, formulation comparison, and supplier qualification programs.

Testing Items

Typical analytical targets for medical PSA pyrolysate characterization include:

• Qualitative identification of thermal degradation products, including monomers, dimers, trimers, and rearranged fragments
• Quantification of residual acrylate monomers such as 2-ethylhexyl acrylate, butyl acrylate, and methyl methacrylate against calibrated standards
• Determination of cyclic siloxane content (D3, D4, D5, D6) in silicone-based adhesives
• Screening of terpene, styrenic, and rosin-derived tackifier decomposition products
• Identification of antioxidant and stabilizer degradation species, including hindered phenol transformation products
• Volatile and semi-volatile organic compound (VOC/SVOC) profiling released at elevated temperatures
• Onset decomposition temperature and mass-loss behavior to establish thermal stability windows
• Toxicological screening of detected compounds against safety concern thresholds and allowable limits derived under ISO 10993-17
• Comparative batch analysis, storage-condition comparison, and failure investigation support

Testing Methods

Pyrolysis-Gas Chromatography-Mass Spectrometry (PY-GC/MS)

A micro-furnace, Curie-point, or resistive-filament pyrolyzer is coupled to a GC-MS system. A 0.1–0.5 mg sample is pyrolyzed at a set temperature between 500 °C and 700 °C in helium, and the resulting fragments are separated on a 5%-phenyl methylpolysiloxane capillary column (30 m × 0.25 mm × 0.25 μm). Electron ionization mass spectra (70 eV, m/z 35–600) are matched against the NIST mass spectral reference library. Double-shot analysis, combining an initial thermal desorption step at 100–300 °C with a subsequent pyrolysis step, distinguishes residual volatiles from true polymer backbone fragments.

Evolved Gas Analysis PY-GC/MS (EGA)

The furnace is programmed from 50 °C to 800 °C at 10–20 °C/min while evolved compounds pass through a short deactivated transfer line directly into the mass spectrometer. The resulting thermogram maps which compounds evolve in which temperature zones, enabling targeted heart-cut GC/MS identification of each decomposition event.

Thermogravimetric Analysis with Coupled Detection (TGA-FTIR, TGA-GC/MS)

TGA quantifies mass loss as a function of temperature under nitrogen or air, providing onset, peak, and completion temperatures for each degradation step. Coupling the TGA off-gas to FTIR or GC/MS delivers simultaneous chemical identification of evolved gases, which is valuable for comparing material stability and sterilization tolerance.

Headspace GC/MS and Thermal Desorption GC/MS

Static and dynamic headspace techniques, as well as sorbent-tube thermal desorption, characterize compounds released at moderate temperatures (40–150 °C), complementing pyrolysis data and supporting extractables and leachables studies conducted under ISO 10993-18.

Sample Preparation and Data Evaluation

Sample handling follows the principles of ISO 10993-12, with conditioned specimens analyzed in replicate to ensure representativeness. Quantitative results are generated by external calibration or internal standard methods, and detected compounds are prioritized for toxicological evaluation according to ISO 10993-17, with analytical evaluations typically targeting identification thresholds in the low microgram-per-gram range.

Applications

Pyrolysis product detection for medical pressure-sensitive adhesives supports the complete product lifecycle:

• Regulatory submissions requiring chemical characterization and degradation product information under ISO 10993-13 and ISO 10993-18 for market approval in major jurisdictions
• Formulation development, raw material selection, and side-by-side supplier or grade comparison
• Sterilization compatibility assessment for heat-based and radiation-based processes
• Root cause analysis of odor complaints, discoloration, loss of tack, and skin irritation or sensitization events
• Accelerated stability, shelf-life, and transport simulation studies linking thermal exposure to chemical change
• Quality control and incoming inspection programs for adhesive raw materials and coated webs
• Environmental and occupational screening of off-gases generated during incineration of PSA-containing medical waste

FAQ

Why is pyrolysis product testing required for medical pressure-sensitive adhesives?

Medical adhesives contact skin for extended periods, and thermal processing, sterilization, storage, or use can liberate residual monomers and degradation products. Regulators expect these compounds to be identified and toxicologically assessed as part of the biological evaluation defined in ISO 10993-1, ISO 10993-13, and ISO 10993-18, and pyrolysate analysis is the most direct way to obtain that information.

How does pyrolysis testing differ from extractables and leachables testing?

Extractables and leachables studies use solvents or simulated-use conditions at mild temperatures to model realistic patient exposure. Pyrolysis testing deliberately forces thermal decomposition to reveal the intrinsic degradation chemistry of the polymer, which supports degradation assessments, thermal process validation, and failure investigations.

What pyrolysis temperature is used?

A single-shot pyrolysis is typically performed between 500 °C and 700 °C, depending on the polymer class. Many laboratories apply a double-shot protocol with an initial thermal desorption at 100–300 °C followed by full pyrolysis, and an evolved gas analysis ramp from 50 °C to 800 °C is used to map decomposition zones before selecting final conditions.

How are the results used in toxicological risk assessment?

Detected compounds are listed with estimated concentrations and screened against published health-based exposure limits and the safety concern threshold methodology of ISO 10993-17. Compounds exceeding analytical or toxicological evaluation thresholds are referred for a chemical-specific risk assessment or targeted quantitative confirmation.

How much sample is needed and what is typical turnaround?

PY-GC/MS generally requires only 0.1–0.5 mg per analysis, so small device cuttings or minor formulation samples are sufficient. Most characterization studies, including evolved gas analysis and reporting with library-based identification, are completed within one to three weeks at accredited third-party laboratories, depending on scope and quantification requirements.